000 01315 a2200373 4500
005 20250516114613.0
264 0 _c20130802
008 201308s 0 0 eng d
022 _a1550-7416
024 7 _a10.1208/s12248-012-9414-x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPourvasei, Ramak
245 0 0 _aSpecific method validation and sample analysis approaches for biocomparability studies of denosumab addressing method and manufacture site changes.
_h[electronic resource]
260 _bThe AAPS journal
_cJan 2013
300 _a70-7 p.
_bdigital
500 _aPublication Type: Journal Article; Validation Study
650 0 4 _aAntibodies, Monoclonal, Humanized
_xanalysis
650 0 4 _aDenosumab
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aHumans
650 0 4 _aRANK Ligand
_xantagonists & inhibitors
650 0 4 _aReagent Kits, Diagnostic
700 1 _aLee, Ed
700 1 _aEschenberg, Michael
700 1 _aPatel, Vimal
700 1 _aMacaraeg, Chris
700 1 _aPandya, Kinnari
700 1 _aShih, Judy
700 1 _aMa, Mark
700 1 _aLee, Jean W
700 1 _aDeSilva, Binodh
773 0 _tThe AAPS journal
_gvol. 15
_gno. 1
_gp. 70-7
856 4 0 _uhttps://doi.org/10.1208/s12248-012-9414-x
_zAvailable from publisher's website
999 _c22174927
_d22174927